ARTELO BIOSCIENCES INC (ARTL)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$6.04-2.89%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ARTL
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | FY 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||||||||
| R&D Expenses | — | 5.4 | 5.4 | 6.0 | 4.3 | 3.8 | 2.8 | 1.9 | 1.1 | 1.2 | — | — | — |
| Operating Income | — | (11.4) | (11.4) | (10.1) | (10.3) | (9.4) | (7.4) | (4.7) | (3.2) | (2.3) | (0.2) | (0.0) | (0.0) |
| Earnings from Continuing Operations | |||||||||||||
| Interest Expense | — | 0.2 | 0.2 | — | 0.0 | — | 0.0 | — | — | 0.0 | 0.0 | — | — |
| Other Non-Operating Income / Expenses | — | (1.5) | (1.5) | 0.3 | 0.2 | 0.0 | 0.0 | 0.0 | 1.0 | (0.0) | (0.0) | — | — |
| Income Tax Expense | — | 0.0 | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — |
| Net Income | |||||||||||||
| Net Income | — | (12.9) | (12.9) | (9.8) | (10.1) | (9.4) | (7.4) | (4.7) | (2.2) | (2.3) | (0.2) | (0.0) | (0.0) |
| Per Share | |||||||||||||
| Basic EPS | — | — | — | — | — | — | — | — | (1.00) | — | — | — | — |
| Diluted EPS | — | (37.75) | (12.52) | (3.05) | — | — | — | — | (1.46) | — | — | — | — |
| Basic Weighted Avg Shares | — | — | — | — | — | — | — | — | 2.2 | — | — | — | — |
| Diluted Weighted Avg Shares | 2.7 | 0.3 | 1.0 | 3.2 | — | — | — | — | 2.2 | 1.3 | — | — | — |
| Supplemental | |||||||||||||
| EBIT | — | (11.4) | (11.4) | (10.1) | (10.3) | (9.4) | (7.4) | (4.7) | (3.2) | (2.3) | (0.2) | (0.0) | (0.0) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.